baber/WOPTO huggingface dataset:
Patent PT-1219541-E (PT)
Inventor: GRANERO TORMO RICARDO
IPC: B65C9/28
Filed: 2000-07-27
Abstract: It has a roller (2) that carries a tape (3) that includes a plurality of labels (4) that run along a guide-wedge (5) that produces a change in direction that produces the detachment of the label (4). It is characterised in that a head (10) has been foreseen connected to a suction circuit (12) and to blower means (13, 15), whose operation is governed by a pneumatic distributor (16), that likewise governs the working of the suction circuit (12), so that when the label (4) has been detached, its suction is produced, and it is retained at the head (10), after which the label is blown (4), to project it energetically over the surface of the product (18) on which it is adhered by the action of the impulsion. The head (10) has a homogeneously multiperforated surface (19) that facilitates the homogeneous impulsion of the label (4). <IMAGE>
Patent PT-1212016-E (PT)
Inventor: FRANC IVERSEN BJOERN
IPC: A61F2/34
Filed: 2000-09-13
Abstract: A tool for use during an operation for implantation of a femoral prosthesis for controlling the mutual positioning of the main components in a femoral prosthesis, i.e. a prosthesis stem (1) with a neck (2) in the patient's femur, and a cup (4) in the patient's pelvic cavity, characterised in that the tool is designed for engagement with a part of the prosthesis stem (1) and/or the neck (2) of the prosthesis, such that the tool can be placed on the implanted prosthesis stem (1) for controlling the mutual angle between the prosthesis stem (1) and the cup (4), and the tool also comprises one or more legs (23) or abutment surfaces (16,24) designed to abut at least a part of that part of the cup (4) that links the exterior of the cup (4) with the recess in the cup (4). <IMAGE>
Patent PT-1192927-E (PT)
Title: Withdrawal spike
Inventor: HEIL NORBERT
IPC: A61M39/26
Filed: 2001-09-26
Abstract: A protective jacket (26) includes a hinged cover (27) that closes a space containing a connecting piece (23). A self-closing valve (31), arranged in a fluid path, opens when a tube is inserted into the connecting piece.
Patent PT-1351734-E (PT)
Title: Dry powder inhaler
Inventor: JEWETT WARREN
IPC: A61M11/00
Filed: 2001-12-18
Abstract: A dry powder inhaler having a housing, at least one single dose storage chamber able to contain a single unit dose, a discharge path adjacent the storage chamber, and a flexible and bendable seal plate closing the discharge path. When an air flow under pressure is applied to the top of the dose, the top seal is broken and the dose is driven against the seal plate which deflects away, allowing the powder of the dose to be driven into and along the discharge path. The air flow causes the seal plate (in the discharge path) to vibrate, which acts to break up the dose into particles of preferred size, as the dose is carried along with the air flow and delivered to a patient.
Patent PT-1267010-E (PT)
Inventor: MICHAEL EGGER
IPC: E04C2/16
Filed: 2002-06-01
Abstract: Wood strand plate has a minimum width of 2.6 m and a minimum length of 7.0 m. Its modulus of flexural elasticity in the principal loading direction is at least 7000 N/mm 2>.
Patent PT-2441449-E (PT)
Title: Modulation of apolipoprotein c-iii expression
Inventor: CROOKE ROSANNE M
IPC: A61K31/00
Filed: 2004-04-15
Abstract: Compounds, compositions and methods are provided for modulating the expression of apolipoprotein C-III. The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein C-III. Methods of using these compounds for modulation of apolipoprotein C-III expression and for diagnosis and treatment of disease associated with expression of apolipoprotein C-III are provided.
Patent PT-1675692-E (PT)
Title: Method and device for detecting a printable surface
Inventor: CAILLON CHRISTOPHE
IPC: B07C3/14
Filed: 2004-07-21
Abstract: The method involves measuring for a postal object, a physical quantity for detecting whether an outer surface of the postal object is made of plastic material, using a gloss detector. A digital image of the surface is formed and is processed to detect whether the surface has an uneven base. The surface is detected as a printable surface or a non-printable surface, based on the result of the two detection. An independent claim is also included for a postal objects sorting machine having an automatic address recognition module, and adapted for implementing a postal object treating method.
Patent PT-1687015-E (PT)
Title: Compositions for the treatment of diseases of the oral cavity and upper respiratory tract
Inventor: BOMBARDELLI EZIO
IPC: A61P31/16
Filed: 2004-11-04
Abstract: Compositions for the treatment of the affections of the oral cavity and upper respiratory tract include anthocyanosides, procyanidins and phloroglucinols. The anthocyanosides are derived from Vaccinium myrtillus extract, the procyanidins are derived from a Vitus vinifera extract, a Camellia sinensis extract or from other edible plants containing procyanidins, and the phloroglucinols are derived from Hypericum spp., Myrtus spp. or Humulus lupulus extracts.
Patent PT-1652520-E (PT)
Title: Formulations useful in the treatment of male and female impotence
Inventor: SEGHIZZI ROBERTO
IPC: A61K36/00
Filed: 2003-05-02
Abstract: Pharmaceutical compositions containing:  extracts of  Tribulus terrestris, Epimedium koreanum, Cinnamon cassia  in the weight ratio of 1.5-3.5 : 1-2 : 0.1-0.4 respectively; 
and optionally  arginine or a physiologically equivalent ester, salt or precursor thereof.    The compositions of the invention are useful in the treatment of male and female sexual dysfunctions.
Patent PT-1719509-E (PT)
Title: Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiogenesisdependent diseases such as cancer and psoriasis
Inventor: SANCHEZ PEDRO CUEVAS
IPC: A61K31/255
Filed: 2005-02-16
Abstract: The invention relates to the use of 2,5-dihydroxybenzenesulfonic acid in the production of medicaments for the treatment of angiodependent diseases. More specifically, the invention relates to the use of the aforesaid compound and, in particular, the calcium and potassium salts thereof, for the treatment of two angiodependent diseases, which present a reduction in the apoptosis, namely cancer and psoriasis. The invention also discloses the antiproliferative, antimigratory, antiangiogenic and proapoptotic capacity of said family of compounds in non-quiescent cells. In addition, the invention details the potentiating effect of said compounds on known cytostatic medicines in the treatment of tumours and, specifically, on gliomas. The invention further relates to the therapeutic efficacy of said compounds, based on the combined antiproliferative, antiangiogenic and proapaptotic capacities threof, in the treatment of chronic psoriatic plaques.
Patent PT-1703914-E (PT)
Title: Apicomplex vaccine strains of a family of sarcocystidae
Inventor: BOUT DANIEL
IPC: C12N1/11
Filed: 2005-01-13
Abstract: Mutant strain (A) of an Apicomplexa of the family Sarcocystidae contains mutations that inactivate both of the adhesins MIC1 and MIC3. An independent claim is also included for a vaccine that contains (A). ACTIVITY : Protozoacide. MECHANISM OF ACTION : Vaccine. Mice were injected intraperitoneally with 20 tachyzoites of T. gondii in which both MIC1 and MIC3 were inactivated, then 1 month later challenged with 70 cysts of the cystogenic strain 76K. Practically no cerebral cysts were formed in the vaccinated animals (99.9 % protection).
Patent PT-1768682-E (PT)
Title: Product of vegetal origin comprising proanthocyanidines and its preparation process
Inventor: MORA BALTASAR RUIZ-ROSO CALVO DE
IPC: A61P9/00
Filed: 2005-06-21
Abstract: A product of vegetal origin with a high percentage of proanthocyanidines with molecular weight of greater than 6000 daltons, a very high percentage of which proanthocyanidines have a molecular weight of greater than 30000 daltons, produces a great hypercholesterolaernic effect at acceptable doses for human consumption and little astringent and anti-nutritional effects. The product of vegetal origin may be presented as medicine, pharmaceutical composition, dietary complement or food product. An industrial process is provided for preparation of the product from dicotyledons.
Patent PT-1812553-E (PT)
Title: Process for the fermentative production of l-valine employing coryneforme bacteria having an enhanced transaminase c activity
Inventor: SAHM HERMANN
IPC: C12N1/21
Filed: 2005-08-19
Abstract: The invention relates to a method for producing L-valine and to a suitable microorganism. The inventive method is characterized by preferably enhancing the transaminase C activity of a coryneform bacterium, especially Corynebacterium glutamicum. The organisms so modified have a yield in L-valine which is 35.8% higher than that of non-modified organisms.
Patent PT-1804213-E (PT)
Title: Method for watermarking a video sequence
Inventor: MITREA MIHAI
IPC: G06T1/00
Filed: 2006-12-07
Abstract: The method involves transforming an image sequence into a transformed sequence, and sequencing coefficients of each transformed image or a zone of each transformed image according to a preset order. A set of coefficients is selected from the sequenced coefficients for each transformed image and is assembled into an operating vector by concatenating the coefficients. The operating vector is processed and inserted in the image sequence. A resistance of the insertion is tested by comparison with a preset reference image and after subjection of the image to attacks and noises.
Patent PT-1951738-E (PT)
Title: Further crystalline forms of rostafuroxin
Inventor: TORRI MARCO
IPC: A61K31/58
Filed: 2006-11-23
Abstract: New crystalline forms of 17β-(3-Furyl)-5-βandrostane-3β,14β,17α-triol are described together with pharmaceutical composition containing the same and methods for their preparation. In particular new Forms B, C, D, E and H are here described.
Patent PT-1969014-E (PT)
Title: Process for starch modification
Inventor: BERCKMANS MARC CHARLES FLORENT
IPC: C08B31/18
Filed: 2006-12-21
Abstract: An etherified thinned starch obtainable by a process comprising the steps of (a) mixing a starch substrate with a thinning agent, an alkalizing agent and an etherification agent; (b) drying the mixture of step (a); and (c) allowing the dried mixture to react with the etherification agent, wherein: the thinning agent consists of one or more hypochlorites; step (a) is carried out at an alkaline pH and does not involve any artificial heating; and step (b) is carried out before the mixture of step (a) reaches the starch substrate's gelatinisation temperature.
Patent PT-1800664-E (PT)
Title: Pharmaceutical formulations for parenteral administration comprising epothilone
Inventor: HOOGEVEST PETER VAN
IPC: A61K31/365
Filed: 1999-02-03
Abstract: Pharmaceutical formulations comprising an epothilone in the form of an infusion concentrate or a lyophilised composition, and methods of administration of an epothilone in suitable form for parenteral administration.
Patent PT-2077907-E (PT)
Title: Roulette game
Inventor: LUTNICK HOWARD
IPC: A63F5/00
Filed: 2007-09-10
Abstract: There is described a roulette game comprising an input device allowing a player to input an ordering of numbers to be displayed on a roulette wheel.
Patent PT-1942622-E (PT)
Title: Carrier synchronization using a preamble and scattered pilot blocks
Inventor: JIANG YIMIN
IPC: H04L7/00
Filed: 2004-06-10
Abstract: An approach is provided for supporting frame synchronization in a digital broadcast and interactive system. A transmitter (200) includes an encoder (203, 309) that outputs a Low Density Parity Check (LDPC) codeword. The transmitter (200) also includes a framing module generates a LDPC coded frame in response to the LDPC codeword, and appends a physical layer signaling field to the LDPC codeword for specifying modulation and coding information associated with the LDPC coded frame. The physical layer signaling field is encoded with a Forward Error Correction (FEC) code and has an embedded framing structure to assist with frame synchronization. The above arrangement is particularly suited to a digital satellite broadcast system (100).
Patent PT-2275010-E (PT)
Title: Device and method for foaming liquid food, in particular milk
IPC: A23P30/40
Filed: 2010-07-13
Abstract: The device has a foodstuff feed line (4), a steam feed line (7) and an air feed line (8) connected to a foaming chamber (5) in a fluid-conducting manner. A control unit (9) controls an intermittent air valve (10) of the air feed line, where the control unit switches the air valve between a high air flow state and a relatively lower air flow and/or airless state. The control unit and the air valve have an interacting construction such that the average air flow of the air valve is controlled by repeated switching between the two states of the air valve. An independent claim is also included for a method for foaming a liquid foodstuff.
Patent PT-714406-E (PT)
Inventor: BUILDER STUART
IPC: C07K14/65
Filed: 1994-08-15
Abstract: A composition is provided comprising about 0.1 to 15 mg/mL of a polypeptide in a buffer having a pH of about 7-12 comprising about 5-40% (v/v) of an alcoholic or polar aprotic solvent, about 0.2 to 3 M of an alkaline earth, alkali metal, or ammonium salt, about 0.1 to 9 M of a chaotropic agent, and about 0.01 to 15  mu M of a copper or manganese salt. The buffer is suitably used in a method for refolding improperly folded polypeptides.
Patent PT-871414-E (PT)
Inventor: GOLDSTEIN STEVEN
IPC: C12N5/07
Filed: 1995-02-27
Abstract: This disclosure includes a method for generating a functional hybrid bioprosthesis. Tissue formed naturally of interstitial collagens is treated to kill native cells and remove potentially immunologically active soluble molecules. Then it may be treated sequentially with extracellular matrix adhesion factor, extracellular matrix glycosaminoglycan, and growth factor appropriate to the cell type required to function within the matrix, and incubating the transplant tissue matrix with cells that are either allogeneic or autologous for the recipient thereby imparting to the matrix the characteristics of the cell type and tissue selected. Tissues with a variety of functional bioactivities can thus be formed in vitro prior to graft transplantation or implantation which will exhibit reduced or no stimulation of an immunological response in the recipient.
Patent PT-767764-E (PT)
Inventor: OLBYE BENDT
IPC: F27B15/00
Filed: 1995-06-01
Abstract: PCT No. PCT/DK95/00216 Sec. 371 Date Oct. 10, 1996 Sec. 102(e) Date Oct. 10, 1996 PCT Filed Jun. 1, 1995 PCT Pub. No. WO96/00703 PCT Pub. Date Jan. 11, 1996A description is given of a plant for heat treatment of lumpy material, such as limestone, other carbonate materials, cement raw materials, or the like. The plant comprises a preheating zone, a burning zone, and connecting means which connect the material outlet of the preheating zone to the material inlet of the burning zone. A separating device is provided as a part of the connecting means and consists of a duct through which a gas stream can be induced to flow from below and upwards. On entry into the separating duct at the top of the duct, the preheated material will be dispersed in the counterflowing gas stream, whereby the material is divided into a fine fraction which suspended in the gas can be discharged via the discharge means provided at the upper end of the duct, and a fall-through coarse fraction which is normal manner can be fed via a connecting means to the material inlet of the burning zone.
Patent PT-737064-E (PT)
Inventor: HENDERSON ANDREW ROY
IPC: A61K9/20
Filed: 1995-10-20
Abstract: PCT No. PCT/GB95/02485 Sec. 371 Date Jul. 18, 1996 Sec. 102(e) Date Jul. 18, 1996 PCT Filed Oct. 20, 1995 PCT Pub. No. WO96/13251 PCT Pub. Date May 9, 1996Process for preparing an oral rapidly disintegrating dosage form of a hydrophobic pharmaceutically active substance comprising forming a suspension of the hydrophobic pharmaceutically active substance in a solvent containing a pharmaceutically acceptable surfactant together with a water-soluble or water-dispersible carrier material, forming discrete units of the suspension and removing solvent from the discrete units under conditions whereby a network of the carrier material carrying a dosage of the hydrophobic pharmaceutically active substance is formed.
Patent PT-849195-E (PT)
Inventor: BRUHMANN WOLFGANG FRIEDRICH WI
IPC: F16D69/02
Filed: 1996-12-20
Abstract: Fitting for rotating drum or carrying conveyor belt comprises elastic material based on natural or synthetic rubber or polyurethane or equivalent in which is incorporated ceramic particles with dimensions between 10 and 2000 microns.
Patent PT-850310-E (PT)
Inventor: CROUZET JOEL
IPC: A61K38/00
Filed: 1996-09-13
Abstract: A novel circular DNA molecule (I), useful in gene therapy, comprises >= 1 sequence of interest, the replication of which is controlled by an origin of replication (ORI) from a plasmid or bacteriophage, which is only active in a host cell in the presence of one or more specific proteins foreign to that cell.
Patent PT-859568-E (PT)
Inventor: SHARON AKIVA
IPC: A61B5/308
Filed: 1996-10-17
Abstract: The present invention relates to an electrodes apron for ECG which is comprised of an apron cast from flexible material to be placed over the chest of the patient, ten electrodes inlaid within the apron in predetermined places wherein six of the said electrodes are located at predetermined distances between the ribs, two under each shoulder and two at both sides of the stomach. Either curved or spiraled conductors are cast within flexible material and each conductor is connected to an electrode. A multiple-pronged cable feeds each of the conductors and includes a connector for connecting the apron to any standard ECG measuring device. The apron also has straps and a belt for tightening the apron on the body of the patient, locating the electrodes of the apron in their required locations for ECG tests.Another preferred embodiment of the present invention is an electrodes apron having two bracelets for attaching to the arms of the patient. Instead of straps for tying, the two bracelets on both sides of the apron are attached to the arms of the patient and when the arms of the patient are brought to their regular position parallel to the body, the apron is tightened over the chest of the patient.
Patent PT-946157-E (PT)
Inventor: GAMACHE DANIEL A
IPC: A61K31/496
Filed: 1997-12-11
Abstract: The present invention relates to the pharmaceutical treatment of pain. In particular, the present invention relates to the topical use of kappa opioid receptor agonists and partial agonists for the prevention or alleviation of pain in the eye.
Patent PT-971938-E (PT)
Inventor: KUBELA RUDOLF
IPC: C07F9/38
Filed: 1998-02-06
Abstract: A process is provided for the preparation of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof which comprises of: a) reacting 4-aminobutyric acid with phosphorous acid and phosphorus trichloride in the presence of a polyalkylene(glycol); and b) recovering said 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof.
Patent PT-968211-E (PT)
Inventor: KLEY HANS-PETER
IPC: A61K31/435
Filed: 1998-03-03
Abstract: PCT No. PCT/EP98/01168 Sec. 371 Date Aug. 30, 1999 Sec. 102(e) Date Aug. 30, 1999 PCT Filed Mar. 3, 1998 PCT Pub. No. WO98/40382 PCT Pub. Date Sep. 17, 1998Compounds of formula (I) in which R4 is a phenyl radical substituted by R5, where R5 is a tetrazole-5-yl-radical optionally substituted by a radical R6, are novel efficacious PDE3/4 inhibitiors.
Patent PT-920352-E (PT)
Inventor: GERHARD GROSS
IPC: B01J8/24
Filed: 1998-05-27
Abstract: The invention relates to a process for carrying out reactions in fluidized beds with transversal introduction of a reactant selected from oxygen or an oxygen-containing gas and a combustible reactant into a fluidized particle bed by transversal injection at supersonic speed by supersonic nozzles.
Patent PT-1003545-E (PT)
Title: Heparin-binding growth factor (hbgf) polypeptides
Inventor: BRIGSTOCK DAVID A
IPC: C12N15/63
Filed: 1998-08-06
Abstract: Substantially pure heparin-binding growth factor polypeptides (HBGFs), nucleic acids encoding the HBGFs and antibodies which bind to the HBGFs of the invention are provided. The HBGF polypeptides axe useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing.
Patent SG-77490-G (SG)
Title: Indole derivatives
IPC: A61K31/40
Filed: 1990-09-21
Abstract: 1. Indole derivatives of the general formula  see diagramm : EP0144012,P18,F1  wherein Ind is an indol-3-yl radical which is substituted by a hydroxymethyl or COW group and which can additionally be monosubstituted or disubstituted by alkyl, O-alkyl, OH, F, Cl or Br, W is H, OH, Oalkyl, NH2 , NHalkyl or N(alkyl)2 , A is -(CH2 )n -, -CH2 -S-CH2 CH2 -, -CH2 -SO-CH2 CH2 -or-CH2 -SO2 -CH2 CH2 -, n is 2, 3, 4 or 5, the two radicals Y are each H or together are a C-C bond, one radical Z is Ar, the other radical Z is H and Ar is a phenyl group which is unsubstituted or is monosubstituted or disubstituted by O-alkyl and/or OH or is substituted by a methylenedioxy group, or Ar is a 2-thienyl or 3-thienyl group, in which formula each of the alkyl groups has 1 - 4 C atoms, wherein, however, when n is 2 or 3, the hydroxymethyl or COW group must be in the 4-, 5-, 6- or 7-position of the indol-3-yl radical, and also physiologically acceptable acid addition salts thereof.
Patent IE-40602-L (IE)
Title: Process for the preparation of 5-sulphamoyl-anthranilic¹acids
IPC: C07C311/39
Filed: 1975-02-13
Abstract: A process for the manufacture of sulfamoyl anthranilic acids of the general formula I (I) in which Ph is phenyl substituted with 1 or 2 halogen atoms, alkyl groups etherified hydroxy groups, and R is aralkyl, heteroaralkyl or cycloalkyl-alkyl, unsaturated in the aliphatic moiety, including oxygen or sulfur and/or substituted with halogen, alkyl or alkoxy in the aromatic moiety, by reacting carboxylic acids with at least one mol-equivalent of an amine ( R-NH2 ) at a temperature above 120.degree.C.
[CA1042896A]
Patent IE-37405-L (IE)
Title: Isoindoline derivatives
IPC: C07D303/36
Filed: 1973-03-14
Abstract: Isoindolin-1-one derivatives substituted on the nitrogen atom in the 2-position by an unsubstituted or substituted phenyl radical or a heterocyclic radical having aromatic characteristics, substituted in the 3-position by a 3-amino(or substituted amino)-2-hydroxypropoxy group, and optionally substituted in the 5- and/or 6-positions by one or two alkoxy radicals or optionally substituted in the 5- and 6-positions by a methylenedioxy radical, possess pharmacodynamic properties, and are especially useful as antiarrhythmic agents. (From US3898232 A) [FR2215951A2]
Patent IE-43574-L (IE)
Title: Radiation sensitive compositions
IPC: G03C1/72
Filed: 1976-03-25
Abstract: This invention relates to a radiation-sensitive copying composition comprising a compound (1) which splits-off an acid upon irradiation and a compound (2) having at least one group selected from the group consisting of a carboxylic ortho acid ester group and a carboxylic acid amide acetal group, which composition, upon irradiation, forms an exposure product having a higher solubility in a liquid developer than the non-irradiated composition.
[US4101323A]